# PIPAC for the Treatment of Colorectal Peritoneal Metastases

> **NCT03868228** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Peritoneal Metastases

## Interventions

- **PROCEDURE:** Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC)

## Key facts

- **NCT ID:** NCT03868228
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-05
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868228, "PIPAC for the Treatment of Colorectal Peritoneal Metastases". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03868228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*